Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 8/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 8/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.48 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.48 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.48 |
| ▸ | HTR1A | P08908 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | PGR | P06401 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.48 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28878493 | 0.98 | CHRM1 (0.50) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL7125777 | 0.81 | CHRM1 (0.54) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Hydrochloric Acid SCHEMBL21800984 | 0.80 | MAPT (0.47) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL2804607 | 0.79 | CHRM1 (0.56) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL28421705 | 0.79 | CHRM1 (0.46) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Hydrochloric Acid SCHEMBL16637633 | 0.79 | CHRM5 (0.56) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL25501824 | 0.79 | ADRA2A (0.52) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL23080917 | 0.77 | ADRA2A (0.50) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| SCHEMBL31627690 | 0.77 | ADRA2A (0.50) | CHRM1CHRM3CHRM2CHRM4CHRM5 | |
| Hydrochloric Acid SCHEMBL23044723 | 0.77 | MAPT (0.54) | CHRM1CHRM3CHRM2CHRM4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0812821-B1 | Carbonic ester of betaine, their preparation and use | AKZO NOBEL NV (NL) | 2000-11-29 | — | — | EP | claimed |
| US-20260116923-A1 | CYCLIC PEPTIDE IL-1BETA TRAP FOR THE TREATMENT OF ATHEROSCLEROSIS AND INFLAMMATORY DISORDERS | MERCK SHARP & DOHME LLC (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2025128805-A1 | A CYCLIC PEPTIDE IL-1BETA TRAP FOR THE TREATMENT OF ATHEROSCLEROSIS AND INFLAMMATORY DISORDERS | MERCK SHARP & DOHME LLC (US) | 2025-06-19 | — | — | WO | disclosed |
| US-9234125-B2 | Corrosion inhibitor systems for low, moderate and high temperature fluids and methods for making and using same | WELLS FARGO BANK, NATIONAL ASSOCIATION | 2016-01-12 | — | — | US | disclosed |
| US-20140128294-A1 | CORROSION INHIBITOR SYSTEMS FOR LOW, MODERATE AND HIGH TEMPERATURE FLUIDS AND METHODS FOR MAKING AND USING SAME | WEATHERFORD/LAMB, INC. (US) | 2014-05-08 | — | — | US | disclosed |
| US-20120302468-A1 | FORMULATIONS AND USES OF DRILLING FLUIDS CONTAINING VISCOSIFIED PHOSPHATE BRINE | CLEARWATER INTERNATIONAL, LLC (US) | 2012-11-29 | — | — | US | disclosed |
| US-20120295820-A1 | MANAGEMENT OF CORROSION IN PHOSPHATE BRINES | CLEARWATER INTERNATIONAL, LLC (US) | 2012-11-22 | — | — | US | disclosed |
| EP-2264119-A1 | High density phosphate brines and methods for making and using same | Clearwater International LLC (US) | 2010-12-22 | — | — | EP | disclosed |
| US-20100305010-A1 | HIGH DENSITY PHOSPHATE BRINES AND METHODS FOR MAKING AND USING SAME | CLEARWATER INTERNATIONAL, LLC (US) | 2010-12-02 | — | — | US | disclosed |
| US-20060194700-A1 | Corrosion inhibitor systems for low, moderate and high temperature fluids and methods for making and using same | WEATHERFORD/LAMB | 2006-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116923-A1 | CYCLIC PEPTIDE IL-1BETA TRAP FOR THE TREATMENT OF ATHEROSCLEROSIS AND INFLAMMATORY DISORDERS | IL1A, IL1B, IL1RN | CHRM1 259/4885CHRM3 1199/4885CHRM2 714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.